​Help monitor COVID-19 patients at home with pulse oximeters

March 31, 2021

This article was revised on March 31, 2021, to update the effective timeline.

Pulse oximeters – the small electronic devices used to measure heart rate and oxygen saturation in a patient's red blood cells – are a useful tool to monitor COVID-19 symptoms at home.

AmeriHealth covers the device for patients under evaluation for or with a confirmed COVID-19 diagnosis to use at home. We have waived member cost-share* (i.e., copayment, deductible, and coinsurance) and referral requirements for this device from June 1, 2020, through June 30, 2021, when supplied by one of our dedicated participating pulse oximetry providers.

If a patient satisfies the clinical coverage criteria in a facility, the discharging physician should provide a prescription to the member with the contact information for one of our dedicated durable medical equipment (DME) suppliers. The member – or medical personnel on behalf of the member – should call the DME supplier directly to arrange home delivery of the pulse oximeter.

The AmeriHealth dedicated participating DME suppliers are:

  • Apria (Phone: 1-855-709-9966; Fax: 1-888-492-0010)
  • Better Living Now (1-877-290-5186)
  • Complete Medical Supplies (1-866-748-5151)
  • Montgomery Medical (610-630-6357)
  • Specialty Medical Products (610-644-1370)

AmeriHealth is committed to providing our members with access to the care they need during the COVID-19 pandemic. We encourage all AmeriHealth members and providers to visit our dedicated AmeriHealth New Jersey and AmeriHealth Pennsylvania COVID-19 webpages regularly for the latest news and updates. We will continue to evaluate member needs as the situation changes.

Learn more

For information about clinical coverage criteria and coding, read the Medical and Claim Payment Policy News Article.

For information about other respiratory equipment and supplies, please read COVID-19 (Coronavirus): Coverage for respiratory equipment and related supplies.

*Self-funded customers can choose to opt out of the cost-share waiver.​